We are making together

Founded in 2017 in Milan, Istituto Gentili is part of the Mediolanum Farmaceutici group and has rapidly evolved into a company focused on oncology, pain and supportive care, building a growing portfolio through strategic partnerships across Europe.

Where we are

Our vision

To be a trusted partner in high value therapeutic solutions, improving patient outcomes by enabling access to innovative therapies and supporting integrated care pathways.

Our history

Our journey is driven by strategic partnerships, portfolio growth and a commitment to improving patient outcomes.

Therapeutic areas

Our portfolio focuses on oncology and onco-hematology, pain, supportive care and pediatric therapies.

Strategic pillars

1

Targeted selection of high-value therapeutic assets in areas of high unmet clinical need.

2

Building strong collaborations to expand access to innovative therapies and accelerate growth.

3

A flexible operating model enabling speed, adaptability and effective delivery across markets.

Distinctive strengths

Focused expertise in oncology and pain therapies

Partnership-driven business model

Agile and efficient execution across markets

Strong network across scientific and healthcare communities

Work with us

Join our team and be part of a dynamic environment bringing innovative therapies to patients.

Partnering

Let’s work together to expand access to innovative therapies and create value for patients.